• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Src、Lyn、Yes和Fyn的差异性转运由SH4结构域中的棕榈酰化状态所决定。

Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.

作者信息

Sato Izumi, Obata Yuuki, Kasahara Kousuke, Nakayama Yuji, Fukumoto Yasunori, Yamasaki Takahito, Yokoyama Kazunari K, Saito Takashi, Yamaguchi Naoto

机构信息

Department of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

出版信息

J Cell Sci. 2009 Apr 1;122(Pt 7):965-75. doi: 10.1242/jcs.034843. Epub 2009 Mar 3.

DOI:10.1242/jcs.034843
PMID:19258394
Abstract

Src-family tyrosine kinases (SFKs), which participate in a variety of signal transduction events, are known to localize to the cytoplasmic face of the plasma membrane through lipid modification. Recently, we showed that Lyn, an SFK member, is exocytosed to the plasma membrane via the Golgi region along the secretory pathway. We show here that SFK trafficking is specified by the palmitoylation state. Yes is also a monopalmitoylated SFK and is biosynthetically transported from the Golgi pool of caveolin to the plasma membrane. This pathway can be inhibited in the trans-Golgi network (TGN)-to-cell surface delivery by temperature block at 19 degrees C or dominant-negative Rab11 GTPase. A large fraction of Fyn, a dually palmitoylated SFK, is directly targeted to the plasma membrane irrespective of temperature block of TGN exit. Fyn(C6S), which lacks the second palmitoylation site, is able to traffic in the same way as Lyn and Yes. Moreover, construction of Yes(S6C) and chimeric Lyn or Yes with the Fyn N-terminus further substantiates the importance of the dual palmitoylation site for plasma membrane targeting. Taken together with our recent finding that Src, a nonpalmitoylated SFK, is rapidly exchanged between the plasma membrane and late endosomes/lysosomes, these results suggest that SFK trafficking is specified by the palmitoylation state in the SH4 domain.

摘要

Src家族酪氨酸激酶(SFKs)参与多种信号转导事件,已知其通过脂质修饰定位于质膜的胞质面。最近,我们发现Lyn作为SFK家族成员之一,沿着分泌途径经高尔基体区域被胞吐到质膜上。我们在此表明,SFK的运输由棕榈酰化状态决定。Yes也是一种单棕榈酰化的SFK,通过生物合成从窖蛋白的高尔基体池转运到质膜。在19摄氏度的温度阻滞或显性负性Rab11 GTP酶作用下,这条途径在反式高尔基体网络(TGN)到细胞表面的运输过程中会受到抑制。双棕榈酰化的SFK——Fyn的很大一部分直接靶向质膜,而不受TGN出口温度阻滞的影响。缺乏第二个棕榈酰化位点的Fyn(C6S)能够与Lyn和Yes以相同的方式运输。此外,构建Yes(S6C)以及带有Fyn N端的嵌合Lyn或Yes,进一步证实了双棕榈酰化位点对于靶向质膜的重要性。结合我们最近的发现,即非棕榈酰化的SFK——Src在质膜和晚期内体/溶酶体之间快速交换,这些结果表明SFK的运输由SH4结构域中的棕榈酰化状态决定。

相似文献

1
Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.Src、Lyn、Yes和Fyn的差异性转运由SH4结构域中的棕榈酰化状态所决定。
J Cell Sci. 2009 Apr 1;122(Pt 7):965-75. doi: 10.1242/jcs.034843. Epub 2009 Mar 3.
2
Rapid trafficking of c-Src, a non-palmitoylated Src-family kinase, between the plasma membrane and late endosomes/lysosomes.c-Src(一种非棕榈酰化的Src家族激酶)在质膜和晚期内体/溶酶体之间的快速转运。
Exp Cell Res. 2007 Jul 15;313(12):2651-66. doi: 10.1016/j.yexcr.2007.05.001. Epub 2007 May 8.
3
The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements.Src、Yes和Fyn的膜靶向及空间激活受棕榈酰化以及不同的RhoB/RhoD内体需求的影响。
J Cell Sci. 2007 Aug 1;120(Pt 15):2555-64. doi: 10.1242/jcs.003657. Epub 2007 Jul 10.
4
Role of Src-family kinases in formation and trafficking of macropinosomes.Src家族激酶在巨吞饮小泡形成和运输中的作用。
J Cell Physiol. 2007 Apr;211(1):220-32. doi: 10.1002/jcp.20931.
5
The residue at position 5 of the N-terminal region of Src and Fyn modulates their myristoylation, palmitoylation, and membrane interactions.Src和Fyn的N端区域第5位的残基调节它们的肉豆蔻酰化、棕榈酰化及与膜的相互作用。
Mol Biol Cell. 2016 Dec 1;27(24):3926-3936. doi: 10.1091/mbc.E16-08-0622. Epub 2016 Oct 12.
6
Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.Fyn 蛋白缺失是Src 家族激酶抑制剂诱导人胸膜间皮瘤细胞凋亡的必要条件。
Carcinogenesis. 2012 May;33(5):969-75. doi: 10.1093/carcin/bgs109. Epub 2012 Feb 21.
7
v-Src and c-Src, nonpalmitoylated Src-family kinases, induce perinuclear accumulation of lysosomes through Rab7 in a kinase activity-independent manner.v-Src 和 c-Src(非棕榈酰化 Src 家族激酶)通过 Rab7 以激酶活性非依赖性方式诱导溶酶体的核周聚集。
Cancer Lett. 2008 Apr 8;262(1):19-27. doi: 10.1016/j.canlet.2007.11.025. Epub 2008 Jan 2.
8
Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cells.HeLa细胞中内源性c-Src、c-Yes和Lyn的差异性有丝分裂激活。
Arch Biochem Biophys. 2007 Oct 1;466(1):116-24. doi: 10.1016/j.abb.2007.07.002. Epub 2007 Jul 14.
9
The cysteine-cluster motif of c-Yes, Lyn and FAK as a suppressive module for the kinases.c-Yes、Lyn和粘着斑激酶的半胱氨酸簇基序作为激酶的抑制模块。
Oncol Rep. 2008 Apr;19(4):975-80.
10
Requirement of the SH4 and tyrosine-kinase domains but not the kinase activity of Lyn for its biosynthetic targeting to caveolin-positive Golgi membranes.Lyn的生物合成靶向至小窝蛋白阳性高尔基体膜需要SH4和酪氨酸激酶结构域,但不需要其激酶活性。
Biochim Biophys Acta. 2009 Oct;1790(10):1345-52. doi: 10.1016/j.bbagen.2009.07.009. Epub 2009 Jul 18.

引用本文的文献

1
Fyn Kinase: A Potential Target in Glucolipid Metabolism and Diabetes Mellitus.Fyn激酶:糖脂代谢及糖尿病中的一个潜在靶点。
Curr Issues Mol Biol. 2025 Aug 5;47(8):623. doi: 10.3390/cimb47080623.
2
Golgi retention of KIT in gastrointestinal stromal tumour cells is phospholipase D activity-dependent.胃肠道间质瘤细胞中KIT的高尔基体滞留依赖于磷脂酶D活性。
Sci Rep. 2025 Aug 6;15(1):28778. doi: 10.1038/s41598-025-14739-w.
3
S-palmitoylation: a novel insight in the development and immunotherapy of oral squamous cell carcinoma.S-棕榈酰化:口腔鳞状细胞癌发生发展及免疫治疗的新见解
J Cancer. 2025 Jun 12;16(9):2787-2799. doi: 10.7150/jca.110721. eCollection 2025.
4
Engineered depalmitoylases enable selective manipulation of protein localization and function.工程去棕榈酰化酶能够对蛋白质定位和功能进行选择性操控。
Nat Commun. 2025 Apr 13;16(1):3514. doi: 10.1038/s41467-025-58908-x.
5
S-acylation of Ca transport proteins in cancer.癌症中钙转运蛋白的S-酰化作用
Chronic Dis Transl Med. 2024 Aug 14;10(4):263-280. doi: 10.1002/cdt3.146. eCollection 2024 Dec.
6
Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders.蛋白质棕榈酰化修饰改变作为神经退行性疾病的发病机制。
J Neurosci. 2024 Oct 2;44(40):e1225242024. doi: 10.1523/JNEUROSCI.1225-24.2024.
7
ACSL3 regulates breast cancer progression lipid metabolism reprogramming and the YES1/YAP axis.ACSL3 调节乳腺癌的进展、脂质代谢重编程和 YES1/YAP 轴。
Cancer Biol Med. 2024 Jul 1;21(7):606-35. doi: 10.20892/j.issn.2095-3941.2023.0309.
8
c-Src-induced vascular malformations require localised matrix degradation at focal adhesions.c-Src 诱导的血管畸形需要在黏着斑处局部降解基质。
J Cell Sci. 2024 Jul 1;137(13). doi: 10.1242/jcs.262101. Epub 2024 Jul 10.
9
Blood-testis barrier: a review on regulators in maintaining cell junction integrity between Sertoli cells.血睾屏障:维持支持细胞间细胞连接完整性的调节剂研究进展。
Cell Tissue Res. 2024 May;396(2):157-175. doi: 10.1007/s00441-024-03894-7. Epub 2024 Apr 2.
10
Non-catalytic role of phosphoinositide 3-kinase in mesenchymal cell migration through non-canonical induction of p85β/AP2-mediated endocytosis.磷酸肌醇 3-激酶在非经典诱导 p85β/衔接蛋白 2 介导的内吞作用中的非催化作用对间充质细胞迁移的影响。
Nat Commun. 2024 Mar 23;15(1):2612. doi: 10.1038/s41467-024-46855-y.